What is the total value of India's pharmaceutical export to Guam?

India exported pharmaceuticals worth $7.0K to Guam across 12 verified shipments.

Who are the top Indian pharmaceutical exporters to Guam?

1. GRAMEEN PHARMA LLP — $7.0K. Total: 1 suppliers.

Which companies in Guam import pharmaceuticals from India?

1. THE MANAGER — $7.0K. 1 buyers total.

What pharmaceutical products does India export most to Guam?

1. Harmless Pharmaceutical Formulation/medicines for Human Consumption Being Humin… ($6.1K, 87.1%); 2. Harmless Pharmaceutical Formulation/medi ($904, 12.9%)

Which ports handle pharmaceutical shipments from India to Guam?

Export: SAHAR AIR, SAHAR AIR CARGO ACC (INBOM4). Import: GUAM.

Why does Guam import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $7.0K corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Guam?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Guam pharmaceutical trade?

$585 per consignment across 12 shipments.

How many Indian pharmaceutical companies export to Guam?

1 Indian companies. Largest: GRAMEEN PHARMA LLP with $7.0K.

How can I find verified Indian pharmaceutical suppliers for Guam?

TransData Nexus covers 1 active exporters with shipment history and trade values at transdatanexus.com.

India to Guam Pharmaceutical Export (2026) — $7.0K, 1 Suppliers | TransData Nexus

India to Guam Pharmaceutical Export (2026) — $7.0K, 1 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Guam

#	Formulation	Value	Share
1	Harmless Pharmaceutical Formulation/medicines for Human Consumption Being Humin…	$6.1K	87.1%
2	Harmless Pharmaceutical Formulation/medi	$904	12.9%

India exports 2+ pharmaceutical formulations to Guam with a combined trade value of $7.0K.. These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 12 verified Indian Customs (DGFT) shipment records.

Top Indian Exporters to Guam

1Grameen Pharma Llp

$7K

1 Indian pharmaceutical companies export finished formulations to Guam. Leading exporters include Grameen Pharma Llp, . The top exporter accounts for 100.0% of total India–Guam pharma exports. Source: Indian Customs (DGFT).

Top Guam Buyers from India

1The Manager

$7K

1 companies in Guam import pharmaceutical formulations from India. Top buyers include The Manager, . The largest buyer accounts for 100.0% of India–Guam pharma imports. Source: Indian Customs (DGFT).

Port Analysis — India to Guam Pharmaceutical Shipments

Indian Export Ports

SAHAR AIR75.0%

SAHAR AIR CARGO ACC (INBOM4)25.0%

Guam Import Ports

GUAM100.0%

Trade Statistics

Total Value$7K

Shipments12

Indian Exporters1

Guam Buyers1

Avg Shipment$585

Products10

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

Supply Chain & Logistics — India to Guam Pharma Shipments

Shipping routes, port infrastructure, cold chain compliance

1Shipping Routes & Transit

Pharmaceutical shipments from India to Guam primarily utilize sea and air transport. Sea freight is the most economical method, with transit times typically ranging from 20 to 40 days, depending on factors such as the specific shipping route, distance, and efficiency of logistics providers. The distance between India and Guam is approximately 6,000 kilometers, contributing to the longer transit time compared to shorter routes. Air freight offers a faster alternative, with transit times of about 6.55 days, including pre-carriage and last-mile delivery.

The major sea route involves shipping from Indian ports to Apra Harbor in Guam, followed by road delivery to the final destination in Dededo Village. Air shipments typically depart from Chhatrapati Shivaji International Airport in Mumbai, India, to Guam International Airport, with subsequent road transport to the destination. It's important to note that the Red Sea disruption, which has affected global shipping routes, may impact sea freight transit times and costs. However, specific data on the extent of this impact on the India-Guam corridor is not readily available.

2Port Infrastructure

In India, the primary export port for pharmaceutical shipments is Chhatrapati Shivaji International Airport in Mumbai, accounting for 75% of shipments, and Sahar Air Cargo Complex (INBOM4), also in Mumbai, handling 25% of shipments. These facilities are well-equipped to handle pharmaceutical exports, offering advanced cargo handling and storage capabilities. In Guam, all pharmaceutical imports arrive at Guam International Airport, which serves as the sole import port for these shipments. The airport is equipped to manage pharmaceutical imports, ensuring efficient processing and distribution.

Market Opportunity Assessment — Guam for Indian Pharma

Market size, healthcare system, growth outlook

1Market Size & Growth

Guam's pharmaceutical market is characterized by a modest scale, with total exports from India amounting to $7,000 USD over 12 shipments between 2022 and 2026. This indicates a nascent trade relationship, suggesting potential for growth. However, specific data on Guam's overall pharmaceutical market size and growth rate are not readily available. The market's import dependency is implied by the limited export value from India, indicating a reliance on imports to meet local pharmaceutical needs. Regarding generic drug penetration, detailed statistics are scarce, but the presence of generic drugs in the market is likely, given global trends favoring cost-effective alternatives.

2Healthcare System

The Government of Guam has transitioned to a self-insured health plan for its employees, effective from Fiscal Year 2024. This model allows the government to directly provide health insurance benefits, administered through a third-party administrator, thereby retaining control over premiums and the claims process. The self-insured plan offers wide access to medical providers in Guam, the U.S. mainland, the Philippines, and other locations. Additionally, the Government of Guam has engaged in agreements with local healthcare providers, such as FHP Health Center, to be an in-network provider for the self-insured health plan, ensuring continuity of care for plan members.

3Opportunity for Indian Exporters

The limited export value of $7,000 USD over 12 shipments from India to Guam between 2022 and 2026 indicates a nascent trade relationship, suggesting potential for growth. The top products exported include various formulations of Huminsulin, accounting for a significant portion of the export value. This suggests a demand for diabetes medications in Guam. Given the self-insured health plan's broad access to medical providers, including those in the U.S. mainland and the Philippines, there is an opportunity for Indian pharmaceutical exporters to supply cost-effective generic drugs to meet the local demand. The growth outlook for Indian pharmaceutical imports into Guam appears promising, considering the government's focus on cost-effective healthcare solutions and the potential for expanding trade relationships.

TransData Nexus Research · Guam healthcare dataMar 2026

Competitive Landscape — India vs Other Pharmaceutical Suppliers to Guam

Competing origins, India's edge, challenges and threats

1Competing Origins

Pharmaceutical suppliers to Guam encompass a diverse range of international and domestic entities. Notable local distributors include MedPharm, MD Wholesale, and CMC Wholesaler Guam, which provide a variety of medical and pharmaceutical products to the region.

While specific data on the market share of pharmaceutical suppliers to Guam is limited, the presence of these local distributors indicates a competitive landscape. Additionally, the U.S. Food and Drug Administration (FDA) oversees the regulation of pharmaceutical imports to Guam, ensuring that all imported drugs meet stringent safety and efficacy standards.

2India's Competitive Edge

India's pharmaceutical industry is renowned for its cost competitiveness, high-quality products, and adherence to international regulatory standards. The country is the largest provider of generic medicines globally, holding a 20% share in the global supply volume and contributing to around 60% of the global vaccines.

India's pharmaceutical sector boasts a broad portfolio, including over-the-counter (OTC) medicines, generics, active pharmaceutical ingredients (APIs), vaccines, biosimilars, and custom research manufacturing (CRM). The industry's strength lies in its ability to offer a wide range of products that cater to diverse medical needs.

3Challenges & Threats

Despite its strengths, India's pharmaceutical exporters face several challenges in the Guam market. Regulatory compliance is a significant hurdle, as the FDA enforces strict standards for pharmaceutical imports, which can be complex and time-consuming to navigate.

Additionally, competition from other suppliers, including those from China and the European Union, poses a threat. These regions may offer products at competitive prices or have established relationships with local distributors, making it challenging for Indian exporters to penetrate the market.

Quality perception also plays a crucial role. While India is known for producing high-quality pharmaceuticals, any lapses in quality can lead to reputational damage, affecting future business prospects.

4India's Position Over Time

India's position in the global pharmaceutical market has been evolving positively. The interim trade agreement framework between India and the U.S., announced in February 2026, offers tariff relief on medicines and other exports, potentially enhancing India's competitiveness in markets like Guam.

However, the actual impact on India's position in the Guam market will depend on the successful implementation of these agreements and the ability of Indian exporters to navigate the regulatory and competitive challenges effectively.

TransData Nexus Research · Global trade databasesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Guam identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 12 verified shipments from 1 Indian exporters to 1 Guam buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

1 Exporters

1 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Guam Pharmaceutical Export